Polysialic acid (polySia), particularly α2,8-linked polyNeu5Ac (DP=8~400), is a unique polymer that spatiotemporally modifies neural cell adhesion molecule (NCAM), predominantly in embryonic brains. PolySia is considered to function as a negative regulator of adhesion between cells, and between cells and extracellular matrix due to its extremely polyanionic nature and steric hindrance. Through its antiadhesive property and spatio-temporal expression, polySia is involved in cell migration, neural outgrowth, axonal guidance, synaptic plasticity, and the development of normal neural circuits and neurogenesis. Due to improvements of polySiadetection methods, it has been shown that polySia expression persists in the hippocampus and olfactory bulb of adults, where neurogenesis is ongoing; however, the functions of polySia, particularly in adult brains, remain incompletely resolved. Recently, we demonstrated that polySia functions not only as an anti-adhesive molecule, but also as a reservoir for specific bioactive molecules, such as neurotrophic factors, neurotransmitters, and growth factors, which regulate neural function. In addition, studies have revealed that the enzymatic activity of STX, which is involved in the synthesis of polySia, derived from schizophrenic patient is low and that the product of the enzyme, polySia on NCAM is impaired with respect to both quantity and quality. Notably, impaired polySia-NCAM cannot effectively retain bioactive molecules, including BDNF, dopamine, and FGF2. Taken together, the impairment of polySia might influence the retention function of polySia and lead to the development of psychiatric disorders, such as schizophrenia, which are reported to express either lower or elevated amounts of polySia compared with normal brains.
acid (Neu5Gc), and deaminoneuraminc acid (KDN; 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid; KDN), from which numerous derivatives arise through acetylation, sulfation, methylation, and lactylation at hydroxyl groups of C-4, -7, -8, and -9; lactonization between the carboxyl group at C-1 and hydroxyl groups; and lactamization between positions C-1 and C-5 (Fig. 1A ). To date, over 50 sialic acid species have been identified (1) ; however, the biological implications of the large diversity of sialic acids remain unclear, although several reports have examined Neu5Gc, KDN and acetylated sialic acids.
Generally, sialic acids are present as monosialyl residues at the non-reducing terminus of glycoproteins and glycolipids, and play important roles in fertilization, development, and differentiation by mediating ligand-receptor interactions between cells (2) . The functional importance of sialic acids has received considerable research attention because a large variety of galactose-binding lectins (galectins) and sialic acid-binding immunoglobulin-like lectins (Siglecs) have been identified in nature (3) . Therefore, we can consider sialic acids to represent "molecules that are recognized". In addition, based on the fact that the phenotype of UDP-Nacetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE)-deficient mice is embryonic lethal, sialic acids also appear to play a pivotal role in embryogenesis (4).
As mentioned above, sialic acids are in most cases present as monosialyl residues at the non-reducing terminus of glycan chains on glycoconjugates and function in various biological activities. However, in some cases, sialic acids are linked to each other to form oligo/polymerized structures ( Fig. 1A) (5) (6) (7) . The oligo/polysialic acids (oligo/polySia) glycotopes also exhibit structural diversity in sialic acid components (Neu5Ac, Neu5Gc, and KDN), sialic acid modifications, intersialyl linkages (α2→4, α2→5Oglycolyl, α2→8, α2→9, and α2→8/9), and degree of polymerization (DP=2~400). In particular, a large diversity in intersialyl linkages has been reported in various tissues of echinoderms, including sea urchins and sea cucumbers, which has been shown to generate functional diversity in sea urchins (8) .
In contrast, nearly all polySia that has been identified in vertebrate brain tissue is α2,8-linked oligo/polyNeu5Ac (5-7). It appears that in the evolution of vertebrates, α2,8-linked oligo/polyNeu5Ac was selected, modified, and improved specifically for modulating brain functions. Therefore, for vertebrates, oligo/polySia diversity might stem from variation in DP, rather than from differences in intersialyl-linkages and Sia modifications. This possibility will be discussed in detail below.
Polysialic acid is a unique and interesting glycotope that serves as an onco-developmental antigen because of its spatio-temporal expression in the embryonic brain and several types of cancers (9) . α2,8-Linked polyNeu5Ac structures with DP greater than 8-10 exist in helical conformation(s) (Fig. 1B ) (10) . As polySia consists of extremely long helical polyanionic chains (DP=8-400), it exhibits hydration effects and has a large exclusive volume. Therefore, the polySia present on cell surfaces functions as a negative regulator between cell-cell and cell-extracellular matrix protein interactions (9) . In fact, the space between cells widens by 10-15 nm in the presence of polySia (11) . PolySia also displays anti-adhesive effects, which is considered to be the most important function of polySia (Fig. 2) . in embryonic brain; however. in adult brain they persist in restricted areas, such as hippocampus and olfactory bulb, where neurogenesis is ongoing. PolySia-NCAM negatively regulates cell-cell and cell-extracellular matrix interactions through steric hindrance due to extremely large exclusion volumes (grey area), i.e., so called, anti-adhesive effect. Non-polysialylated NCAMs are expressed in wide areas of adult brain and interact with NCAM, other CAMs, and receptors to form the intercellular space narrower than polySia-NCAM. Ig dmain, immunoglobulin domain; FnIII domain, fibronectin type III domain.
Recently, the biosynthetic pathways of polySia have been elucidated, and mice deficient in the enzymes responsible for polySia expression have been developed (12) . In addition, in the course of development and improvement of detection methods for polySia, several new polySia-containing glycoproteins have been discovered. The application of these detection methods to the study of polySia-related interactions (32, 34, 35) has revealed novel functions of polySia. In this mini-review, we will introduce the newly discovered functions of polySia and discuss the relationships between polySia and psychiatric disorders, particularly schizophrenia, which have been reported to date.
B. History of the Discovery of PolySia-Containing Glycoconjugates
PolySia was first found in neuro-invasive bacterial polysaccharide chains in 1957 (9) . In vertebrates, polySia was first reported from polysialoglycoprotein (PSGP) derived from salmonid fish eggs (10) . As PSGPs are localized in the egg cortical alveolar and are exocytosed into perivitelline spaces immediately after fertilization, PSGPs are considered to be involved in embryogenesis. PolySia was later shown to be present on neural cell adhesion molecules (NCAMs) derived from chick and rat embryonic brains (14) . At that time, the polySia on NCAM was considered to be exclusively present in brains during embryonic stages and to exhibit spatiotemporal expression patterns. In addition, the same expression pattern of polySia in embryonic brain was demonstrated to occur in fishes, birds, reptiles, and amphibians. Therefore, polySia has been considered to function as an important glycotope in critical and common brain functions during embryonic developmental stages. Subsequently, numerous functional analyses of polySia, particularly on its role during neurogenesis, have been explored.
Recently, due to improvements in detection methods for polySia, important new findings have accumulated. For example, (poly) Sia structures have been demonstrated in insects (fly and cicada) (15, 16) . In addition, polySia-NCAM has been detected in not only vertebrate brains, but also in kidney, heart, and natural killer (NK) cells (in humans) (9) . Several types of cancer cells, including neuroblastoma, Wilms' tumors, and small cell lung carcinomas, display polySia, which is considered to be involved in the detachment and metastasis of tumor cells through its anti-adhesive effects. PolySia-NCAM is only expressed in adult brains in restricted areas, such as the hippocampus and olfactory bulb, where neurogenesis is ongoing (17, 18) . In addition, several polySiacontaining glycoproteins other than PSGP and NCAM have been reported, including the sodium channel of electric eel, α-subunit of the sodium channel from rat brain (19) , CD36 present in human milk (20) , neuropilin-2 in human lymphocytes (21), SynCAM-1 from mouse brain (22) , and flagellarsialin in sea urchin sperm (23, 24) . These new findings suggest the likely existence of other novel polySia-containing glycoconjugates in vertebrates.
C. Anti-Adhesive Effect of PolySia NCAM is the most familiar polysialylated molecule and is mainly expressed in embryonic brains of vertebrates. The function of polySia has been well studied for NCAM, which consists of five immunoglobulin-like (Ig) domains with six N-glycosylation sites and two fibronectin type-IIIlike (FNIII)-domains in the extracellular region. PolySia chains are linked to the tri-or tetra-antennary N-linked glycan chains on Ig domain V of NCAM. NCAM is attached to the cell surface via a GPI anchor (NCAM-120) or spans the membrane into the cytosol via cytosolic regions (NCAM-140 and NCAM-180) and transmits extracellular signals inside the cell (Fig. 3) . A soluble form of NCAM (sNCAM) has been also reported. The different isoforms of NCAM are thought to be mediate the generation of a variety of signals and regulate cell adhesion by altering membrane localization (25) .
The major isoform involved in the transmission of signals into cells is NCAM-180. The cytosolic region o f N C A M -1 8 0 c o n t a i n s a p a l m i t o y l a t i o n a n d t w o phosphorylation sites. Among the known molecules that interact with NCAM, spectrin, Fyn, and FAK bind to the cytosolic region of NCAM-180. Later studies demonstrated that the interaction between NCAM, spectrin, and PKCβ2 leads to neurite outgrowth (Fig. 3) . Homophilic interaction between non-polysialylated NCAMs accelerates the phosphorylation of FAK, recruits adaptor proteins such as (Fig. 3 ).
Homophilic and heterophilic interactions mediated by non-polysialylated NCAMs on the cis membrane in the same cell and on trans membranes between cells lead to a series of signal transduction events, as described above. On the contrary, as polySia-NCAMs are expressed in restricted areas and negatively regulate NCAM-mediated interactions, polySia is considered to be a negative regulator of NCAM-mediated signal transductions (Fig. 4A ). To better understand the functions of polySia, such as its potential role in anti-adhesive effects, NCAM knock-out (KO) mice (26) and STX (ST8SiaII) and/or PST (ST8SiaIV) KO mice that cannot synthesize polySia were developed. Biochemically, STX and PST are the enzymes responsible for the biosynthesis of polySia and are able to synthesize polySia either alone or together. In studies with NCAM-deficient mice, a number of phenotypes, such as decreased brain weight, and impairment of long-term potentiation (LTP), spatial learning, and circadian rhythm have been observed. However, the phenotypes are relatively mild. PST-KO and STX-KO mice also exhibit a few of the same phenotypes, which are also mild, as NCAM-KO mice. Thus, to realize non-polySia conditions in the brain, STX and PST double-KO mice were developed (29) , and the resulting phenotypes were severe, with almost all mice dying soon after birth. From these results, the structure of polySia, not only on NCAM, but also on other polySia-containing glycoproteins, plays a direct and important role in both brain and other yet unknown tissue functions. Interestingly, the phenotypes of NCAM, STX, and PST triple-KO mice were not as deleterious as those of polySia-KO mice, i. e., STX-and PST-KO (12) .
The above results were interpreted based on the cell adhesion mediated by NCAM and the subsequent signal transduction. It appears that single-gene deficiency in STX or PST decreases polySia expression, but only leads to slight functional defects of brain function, as significant amounts of polySia persist in the brain and perform the major function(s) of polySia. If polySia disappears completely by knocking out both polysialyltransferases, the mice die because brain functions are largely impaired due to the increased strength of interactions between cells resulting in incorrect signal transmission (i.e., excess transmission). In the case of triple-KO mice, excess signal transmissions through increased interactions between polySia-KO cells are likely markedly reduced due to the lower amounts of cell adhesion molecules present resulting from the knock out of NCAM. The reduction of NCAM leads to the normal physiological interaction between cells and the rescuing of the phenotypes observed with polySia-KO mice. In summary, it appears that the attenuation of signal transduction by the deletion of NCAM rescues the intimate interaction between cells derived from polySia-KO mice and leads to normal development (12) .
Together, all of the data suggest that polySia functions as a spacer to regulate the gap between cells. The steric effects of polySia may spatio-temporally regulate not only cis interactions between homophilic and heterophilic molecules on the same cell, but also trans interactions between these molecules on different cells (Fig. 3) , and these complicated interactions might lead to normal neurogenesis and neural development. However, it is true that the phenotypes of STX-, PST-, and NCAM-KO mice include abnormalities of neurogenesis and neural development, and also impairment of the maintenance of adult neural functions. Therefore, the functions of polySia, particularly in adult brains, should be comprehensively examined in detail. Interestingly, we and other groups have demonstrated novel functions of polySia, which will be introduced in the next section.
D. New Functions of PolySia-1: Retention and Release of Bioactive Factors of Neural Function
Recently, we demonstrated that polySia directly binds to soluble bioactive factors and regulates their functions (7).
Thus, polySia appears to retain and regulate the function of specific bioactive factors in the gaps between cells covered by polySia, suggesting that polySia displays an attractive field for these bioactive molecules (Fig. 4C ). The function of "retaining bioactive factors of neural function" clearly indicates that polySia is involved in not only neurogenesis, but also in the regulation of neural functions via bioactive molecules. This novel function of polySia completely differs from the anti-adhesive effect on interactions between cellcell and cell-extracellular matrix that are mediated by its bulky and exclusive volume (i.e., repulsive field) (Fig. 4A) , as described above. In addition, we have demonstrated that a microglia cell line contains α2,8-linked polyNeu5Ac and that polySia disappears rapidly in these cells after inflammatory stimulation with lipopolysaccharide (LPS) (30, 31) . The rapid clearance of polySia on the microglia cell surface indicates that these cells can supply trophic factors which bind to polySia, immediately after LPS stimulation. This represents one of the mechanisms for releasing bioactive molecules captured by polySia. Therefore, we are hypothesizing that polySia has new functions:, retaining and releasing bioactive molecules. To demonstrate this hypothesis, we are testing various types of molecules present in brain that interact with polySia, such as trophic and growth factors, hormones, and neurotransmitters. In addition, we are analyzing the releasing mechanism of polySia. In this section, we will introduce brainderived neurotrophic factor (BDNF) (32, 33) , catecholamines (dopamine) (34, 35) , and a growth factor (FGF2) (36) as polySia-interacting molecules. D-1. Neurotrophin-BDNF BDNF, which is a member of the neurotrophins, displays 50% homology with neural growth factor (NGF) and is the most abundant in brain tissue. BDNF promotes the growth and development of immature neurons and enhances the survival and functional maintenance of adult neurons through both a high-affinity receptor, TrkB, and a low-affinity receptor, p75NTR. This neurotrophic factor also has a vital role in the neural plasticity that is integral to memory and learning. Notably, it was also shown that polySia-NCAM is involved in memory and learning based on the analyses of NCAM-KO mice. Kiss et al. (37) reported that the addition of BDNF to slices of hippocampus derived from NCAM-KO mice rescued the reduction of LTP resulting from the disappearance of polySia-NCAM, indicating that polySia-NCAM is involved in signal transduction mediated by BDNF receptors. In addition, neural cells lacking polySia-NCAM enhance BDNF signals through p75NTR. To understand the relationships between polySia-NCAM and BDNF signals, it is necessary to analyze the relationships between polySia, BDNF, and BDNF receptors in detail. Therefore, we first attempted to determine if polySia directly interacts with BDNF using gel filtration, horizontal native-PAGE, and surface plasmon resonance (SPR) methods (32) . We demonstrated that BDNF dimers bind to polySia directly and that the minimum requirement of DP of polySia is 12 or greater for complex formation between BDNF and polySia. Notably, this was the first study to demonstrate the biological significance of the DP of polySia. In addition, we also showed that the resulting complex between polySia and BDNF is extremely large (approximately 2500 kDa). Based on titration and gel filtration experiments, this super-complex was found to consist of 14 mol BDNF molecules (dimer) and 28 mol polySia (DP av. = 43) . It is important to analyze the "structure" and "physical features" of this complicated complex in detail. We also analyzed the interactions between polySia and several neurotrophins other than BDNF (32) . However, the binding affinity of BDNF toward polySia was the strongest among the examined factors, followed by NT-3 and NGF. The binding affinity of NT-4 toward polySia was extremely weak. The observed binding affinities might be affected by the total number of basic amino acids in neurotrophins, however, we speculate that they are specifically influenced by the 2-4 basic amino acids sequences in the C-terminus of neurotrophins. However, further analyses of the structural factors influencing complex formation by crystallographical methods are needed to confirm this speculation.
We next examined if ternary complex formation occurs between polySia, BDNF, and BDNF receptors using gel filtration analysis of these molecules in various combinations. We demonstrated that BDNF-polySia complexes do not consist of a ternary complex with BDNF receptors, and that BDNF molecules forming a complex with polySia easily migrate toward receptors. This migration can be explained by the affinities of BDNF towards polySia and its receptor. The KD of BDNF towards polySia, as calculated by the SPR method, is approximately 10 -9 M (35). In contrast, the KDs of BDNF towards TrkB and p75NTR are 10 -12 and 10 -10 M, respectively. Based on these results, BDNF making complex with polySia easily migrate toward receptors because BDNF has a one to three orders of magnitude stronger affinity toward BDNF receptors than that towards polySia (Fig. 5A) .
The effects of polySia and polySia-BDNF complexes on cell proliferation of neuroblastoma cells expressing TrkB and p75NTR were also evaluated. We found that cell proliferation increased in the presence of polySia and polySia-BDNF complexes compared with cells to which no addition was made. Interestingly, the effects of polySia-BDNF complexes continue markedly longer as compared with those of polySia only. Thus, these findings demonstrate that the complex between polySia and BDNF activates cell growth As described, polySia is present in the two N-linked glycan chains attached to the Ig V domain of NCAM. Based on the fact that polySia modification exists close to the cell surface and that two polySia chains binds to a single BDNF dimer, it appears that polySia-NCAM interacts and forms a complex with BDNF close to the cell surface, where it serves to regulate the cells (cis interaction). PolySia might retain bioactive molecules such as BDNF by specific binding mechanisms, which remain to be proven, and effectively display these molecules to the respective receptors (Fig. 4C,  Fig.5 ).
We also analyzed the interactions between polySia and proBDNF, the precursor of BDNF (Hane, M., Ono, S., Kitajima, K. and Sato, C., unpublished results). ProBDNF is cleaved by cytosolic protease to generate a prodomain and BDNF, which is subsequently secreted extracellularly. Secreted BDNF is thought to be involved in receptor binding and the functioning of receptors. Recently, it was reported that proBDNF is secreted outside of cells, where it is cleaved by tPA/plasmin and processed to mature BDNF. Interestingly, extracellularly processed BDNF is reported to play a pivotal role in memory (38, 39) . We have recently shown that in addition to binding BDNF, polySia also binds proBDNF, but does not bind to the prodomain. We have also Left panel shows the sialidaseor pH-mediated release mechanism. PolySia can be cleaved by extracellular sialidases or under the acidic conditions (low pH). PolySia also changes its conformation depending on the pH in solution. The degradation and conformational changes of polySia may release the bioactive molecules from polySia-NCAM to supply to the surrounding area. Right panel shows the specific receptor-mediated mechanism. For example, the brain-derived neurotrophic factor (BDNF) in the BDNF-polySia complex migrates to its receptors, TrkB or p75NTR, according to differences of the affinity between BDNF, the receptors, and polySia. In the case of fibroblast growth factor 2 (FGF2), polySia does not release FGF2 from the FGF2-polySia complex to FGF receptor (FGFR). Interestingly, FGF2 in the FGF2-polySia complex can migrate to heraran sulfate (HS) to form the FGF2-HS complex, which can bind to FGFR as a ternary complex to enhance FGF signaling. Therefore, polySia regulates FGF2 signaling by passing FGF2 to HS and finally FGFR.
analyzed the protection effect of BDNF complexed with polySia through the action of serine proteases. PolySia might regulate the tPA/plasmin cleavage process for proBDNF by binding to proBDNF and/or BDNF. In the brain, several polyanionic molecules other than polySia are present, for example, glycosaminogycans on proteoglycans, and it is possible that such polyanionic chains might also be involved in the same cleavage process. In fact, we showed that several glycosaminoglycans are able to bind BDNF specifically (33) . Thus, it is important to understand the structures and features of glycosaminoglycans and polySia, in addition to their cellular localization.
D-2. Neurotransmitters-Catecholamines
The binding between polySia and catecholamine neurotransmitters has been demonstrated by frontal affinity chromatography (FAC) (34, 35) . Although FAC is a wellknown method to analyze interactions between glycans and lectins, these studies are the first application of FAC to analyze the interactions between glycans and small molecules. FAC analyses showed that polySia specifically binds to catecholamines, particularly dopamine, among numerous examined factors, including histamine, acetylcholine, serotonin, catecholamines (dopamine, epinephrine, and norepinephrine), and their precursors (34, 35) . As the binding was not observed with diSia, catecholamine binding appears specific to polySia, and these interactions might occur between specific structures of both polySia and catechol, but not through electrostatic interactions. As the KD of dopamine towards polySia changes depending on the pH of the solution (35), the specific interaction between these molecules might be fine tuned by subtle changes of extracellular pH. Interestingly, we observed that the conformation of polySia changes depending on the pH (pH 5~8), as revealed by CD measurements (Sato, C. and Kitajima, K, unpublished results). Based on these results, subtle changes of polySia conformation might regulate the retention and subsequent release of dopamine.
PolySia has been shown to be involved in the Akt signaling of neuroblastoma cells via dopamine receptors (34) . These results suggest that the polySia-NCAM localized on postsynaptic membranes directly interacts with catecholamine neurotransmitters, representing a novel function of polySia.
D-3. Growth factors-FGF2
FGF2 is a prototypical FGF that stimulates the growth of various cell types, from fibroblasts to tumor cells, and was first identified in the bovine pituitary gland as a factor with the potential to induce the proliferation of fibroblast cells. Twentytwo FGF molecules have been identified to date. Among FGF, FGF2 has been shown to be important for brain development and proliferation of neural cells. FGF2 mediates cellular signal transduction through the binding of FGF tyrosine kinase 
receptors (FGFRs). It is well known that FGF2-FGFR signals
are enhanced following the formation of ternary complexes with heparan sulfate (HS), which is a component of the extracellular matrix. PolySia is expressed in restricted areas of the adult brain, such as the hippocampus and olfactory bulb, where neurogenesis is ongoing, and is a marker of neural stem cells. Therefore, we attempted to determine if polySia directly interacts with FGF2 using several methods, including gel shift assays, gel filtration, and SPR (36) . Of note, we developed a new SPR method to determine the dissociation constant of FGF2 toward polySia that involved removing the non-specific binding of FGF2 as the analyte. We immobilized polySia and polySia-NCAM on Au surfaces lacking carboxymethyldextran, which occasionally leads to non-specific binding, particularly when basic proteins are used as analytes. We also improved the method to immobilize (GlcNAc) 3 as a negative control for FGF2 binding (35, 36) . Using this approach, we demonstrated that: 1) FGF2 binds to polySia directly; 2) FGF2 monomers bind to polySia and form a large complex; 3) FGF2 complexed with polySia does not migrate to receptors, even if the receptors are located in the immediate vicinity; and 4) the KD of FGF2 towards polySia is smaller than that towards HS and NCAM. Interestingly, the properties of FGF2-polySia and FGF2-HS complexes are distinct, because although the former can bind to HS or polySia surfaces, the latter cannot bind to either modified surface. These results indicate that the binding regions of FGF2 toward polySia and HS differ. In addition, the sizes and biochemical features of these two types of complexes are also distinct from each other. Furthermore, FGF2 complexed with polySia cannot migrate toward FGFR, but it can migrate toward HS. As the KDs of FGF2 toward polySia and HS are nearly identical (FGF2 has a slightly strong affinity toward polySia), it is possible to transfer FGF2 from polySia to HS (Fig.5, right panel) . Taken together, these results suggest that another FGF2 signaling pathway is directly mediated by NCAM via the polySia present on NCAM, and is distinct from that mediated by NCAM and FGFR interaction.
E. New Functions of PolySia-2: Regulation of Ion Transport through Membranes
PolySia displays anti-adhesive fields that serve to negatively regulate cell adhesion. However, it is clear that polySia also exhibits adhesive fields with bioactive factors, including BDNF, FGF2, and dopamine, as described above. Recently, this property has been found to be associated with the novel function of polySia as a regulator of ion transport through membranes, which will be introduced here.
E-1. Flagellasialin from Sea Urchin Sperm Membrane
In the sperm of sea urchin, an α2,9-linked polySia structure (average DP of 15) was identified on the cell surface (23, 24) , representing some of the first few reports of α2,9- Thus, flagellasialin is the glycoprotein that displays α2,9-polySia structures on the sperm cell surface in sea urchin.
To understand the function of polySia in fertilization, we developed and used two specific antibodies, 4F7 and 3G9, which recognize the internal (→9Neu5Acα2→)n and terminal (8-O-sulfated Neu5Acα2→9) structures, respectively, of the polySia chain (24) . However, our analyses demonstrated that only 4F7 completely inhibited sperm motility. For sperm motility, it is necessary for cells to regulate the concentrations of several ions, particularly Ca 2+ , whose concentration must be low in sperm cells to permit free movement. For sea urchin sperm motility, two important ion regulators for maintaining low Ca 2+ concentrations, namely K + -dependent Na + /Ca ]i, resulting in the cessation of sperm motility. These results suggest that the internal structure of the polySia chain is important for the regulation of intracellular Ca 2+ concentrations. Therefore, the polymerized α2,9-linked polySia structure appears to be involved in sperm movement by correctly regulating Ca 2+ concentrations through the binding of regulator proteins, likely suNCKX and suPMCA, which are involved in the regulation of the influx and efflux of Ca 2+ in sperm.
We have also analyzed the Ca 2+ dependent motility of sea urchin tail and demonstrated that flagellasialin is involved in Ca 2+ efflux after mechanical stimulus (40) . The motility of sperm tail can be classified as two types: one is propulsion and the other is directional regulation. Ca 2+ -dependent motility of sea urchin sperm tail is related to the directional regulation of sperm by regulating the tail-beating movements. Sperm typically moves in circular traces and upon encountering an obstacle, it stops, changes direction, and re-initiates movement with a circular trace. Thus, the movement of sea urchin sperm can be classified as follows: movement with a circular trace (CB)→mechanical stimulation→stopping (Q)→reverse change of sperm head→movement with a straight trace (S)→ movement with a circular trace (CA). Among these sequential movements, we identified that α2,9-linked polysialic acid on flagellasialin and suPMCA is involved in the course of Q→ S and that suNCKX is involved in the course of S→ CA (40) . 
Thus
, it is important to analyze the mechanism of complex formation between flagellasialin, PMCA, and NCKX in these sequential movements.
E-2. PolySia NCAM on the Postsynaptic Membrane Derived from Vertebrates
The same phenomenon that is observed in sea urchin sperm has been demonstrated using postsynaptic membranes derived from vertebrates. Recently, it was reported that polySia on NCAM regulates the function of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor and N-methyl-D-aspartate (NMDA) receptors on synapses. Using reconstituted membranes containing glutamate receptors with polySia-NCAM, polySia-NCAM was found to potentiate AMPA receptor currents (42) . PolySia-NCAM has also been reported to inhibit the function of NR2B-containing receptors (NMDA) and prevent glutamate-induced cell death (41) . These findings suggest that polySia-NCAM is involved in synaptic function in the hippocampus toward different types of channels that are differentially regulated. In these cases, it is proposed that polySia-NCAM binds to a portion of channel proteins and regulates the period the channels are open (Fig.  4B ).
F. Impairment of Polysialic Acid Structure and Psychiatric Disorders-Schizophrenia
BDNF and dopamine are two molecules that can bind to polySia and have a well-established association in schizophrenia (43, 44) . In addition, the polySia-binding protein FGF2 also appears to be involved in both mood disorders (45) and adult neurogenesis (46) . Interestingly, a few studies have identified a relationship between polySia-NCAM and brain samples from schizophrenic patients (47, 48) . For example, the immunostaining of polySia-NCAM derived from the hippocampus of schizophrenic brains decreased compared with that of normal brains (47) . It is also reported that the volume of olfactory bulbs derived from schizophrenic brain is reduced, which is a similar phenotype to that of NCAM-KO mice (48) . In addition, several characteristic properties, such as brain structure, neural plasticity, and behaviors have been found in STX-or PST-KO mice (7). Furthermore, chromosome 15q26, which is the genomic region where STX localizes, is related to schizophrenia and bipolar disorders among the population of Eastern Quebec (49). In 2006, Arai et al. (50) demonstrated that there is some relationship between SNPs in promoter region of STX and schizophrenia by genome-wide research (50) . Based on these facts, we are thinking that the impairment of polySia function as a regulator of bioactive molecules such as BDNF, dopamine, and FGF2 might cause a number of psychiatric disorders, including mood disorder and schizophrenia, in which polySia expression is altered compared with the levels in normal brains. Therefore, we are currently examining the impairment of polySia biosynthesis and the retention function of bioactive molecules that are closely related to the psychiatric disorders.
To demonstrate this association, we are focusing on SNP-7 (Glu141Lys) and SNP-9 (Pro201Pro) in the coding region of STX reported by Arai (34) .
In regard to the in vitro enzymatic activity of STX toward NCAM-Fc, STX containing SNP-7 showed markedly lower activity than that of wild-type STX. In contrast, the enzymatic activity of STX containing SNP-9 was nearly identical as that of wild-type STX, as expected. On examination of the in vivo enzymatic activity using cells transfected with the SNP-containing isoforms of STX, STX with SNP-7 showed much lower activity toward NCAM than that of wild-type STX, and the DP of NCAM had also decreased compared with that from wild-type cells. Although these results were consistent with the reported results for schizophrenic brains, unexpectedly, the enzymatic activity and DP of NCAM were also impaired in cells transfected with STX containing SNP-9. Purified polySia-NCAM-Fc derived from cells stably transfected with plasmids encoding wildtype, SNP-7, and SNP-9 STX were subsequently used for the analysis of binding affinity towards BDNF and FGF2 by SPR, and towards dopamine using FAC. Compared with wild type, the binding of polySia NCAM-Fcs derived from STX with SNP-7 showed a lower binding affinity toward BDNF and FGF2 (1/5 and 1/10, respectively). Lower binding affinity was also observed for polySia NCAM-Fcs derived from STX with SNP-9. Taken together, these results suggest that changes of quantity and quality, such as DP, of polySia on NCAM lead to altered binding affinity toward BDNF, FGF2, and dopamine, and may be one of the underlying causes of schizophrenic The level of polySia in quantity and quality (e.g., DP) may be different from person to person, as has been reported for patients suffering from psychiatric disorders and other neurodegenerative diseases. Direct and indirect lines of evidence show that quantity and quality of polySia on NCAM are critically important for the normal brain functions. Hyper-or hypo-polysialylation of NCAM might bring about impairment of polySia functions (see Fig. 5 ), leading to impairment of brain functions through the hyper-or hypo-effects on dopamine-, BDNFand FGF2-mediated signaling.
conditions (34) .
It should be noted that SNP-9 (Pro207Pro) is a silent mutation and does not affect the primary amino acid sequence of STX, whereas SNP-7 (Glu141Lys) leads to a one amino acid change. The mutated amino acid localizes near sialyl motif L and was clearly shown to be important for the enzymatic activity of STX. As SNP-9 is a silent mutation, it is reasonable that STX containing SNP-9 maintains enzymatic activity in vitro. However, we need to carefully evaluate the results indicating that STX with SNP-9 exhibits lower in vivo enzymatic activity and cannot produce high quality polySiaNCAMs compared with STX from wild type. To explain these findings, it is necessary to consider the conformation of mRNA, codon usage ratio, and amount and localization of STX during transcription and/or translation.
As psychiatric disorders such as schizophrenia are complex diseases with multiple factors contributing to pathogenesis, the mechanisms by which polySia is involved in these disorders are also likely complex. However, it is clear that the quality and quantity of polySia-NCAM is strictly regulated in normal cells and that the impairment of polySia has severe effects on various brain functions through reduced binding affinity toward biologically active molecules (Fig.  6 ). Such impairment might result in psychiatric disorders or have effects on the prognosis of these diseases. Interestingly, imbalances of polySia-NCAM are also reported in patients suffering from Parkinson's and Alzheimer's diseases (51, 52) , and drug abuse, other than schizophrenic patients. In addition, the elevated expression of polySia-NCAM has been observed in the brains of patients with these diseases. Thus, further studies to analyze the quality of polySia derived from the brains of these patients are needed.
G. Conclusions
Since the first reports several decades ago, it has been proposed that polySia negatively regulates cell adhesion and that spatio-temporal expression of polySia is necessary for normal neurogenesis and brain function (Fig. 4, upper panel) . More recently, it has been demonstrated that polySia directly binds to a number of neurotrophic factors, neurotransmitters, growth factors, and ion channels, thereby regulating their functions (Fig. 4B) . Based on these findings, polySia appears to display two different fields on the cell surface in two ways. The first is a repulsive field that mediates anti-adhesive effects, and the second is an attractive field involved in retention and reservoir functions. Based on the volume of polySia that influences the cellular environment, these two fields might be present at the same time on the cell surface. Therefore, the situation surrounding the functions and influence of polySia is not simple. To better understand the underlying molecular mechanisms that fine-tune the neural functions of polySia, comprehensive studies to elucidate the structure, biosynthetic mechanisms, and localization mechanisms of polySia are required.
て理解していく必要がある。
